Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL866 | 0.85 | — | — | |
| Dibromodifluoromethane SCHEMBL11771415 | 0.82 | — | — | |
| Trichloromonofluoromethane SCHEMBL4620269 | 0.80 | ALDH1A1 (0.30) | LMNA | |
| Dichlorodifluoromethane SCHEMBL5014895 | 0.80 | ALDH1A1 (0.30) | LMNA | |
| Charcoal, Activated SCHEMBL30130135 | 0.80 | — | — | |
| Fluoride SCHEMBL27295812 | 0.80 | — | — | |
| Trichloromonofluoromethane SCHEMBL11344324 | 0.80 | ALDH1A1 (0.33) | LMNA | |
| Dichlorotetrafluoroethane SCHEMBL554874 | 0.76 | ALDH1A1 (0.31) | — | |
| Chloropentafluoroethane SCHEMBL11557068 | 0.76 | — | — | |
| Dichlorotetrafluoroethane SCHEMBL22832126 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230405215-A1 | METHODS AND DEVICES FOR MANAGING FLUID PRESSURE | FEMASYS INC. | 2023-12-21 | — | — | US | disclosed |
| US-11806500-B2 | Methods and devices for managing fluid pressure | FEMASYS INC. (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230240716-A1 | CONTRAST AGENT GENERATION AND INJECTION SYSTEM FOR SONOGRAPHIC IMAGING | FEMASYS INC. | 2023-08-03 | — | — | US | disclosed |
| US-11648033-B2 | Methods and devices for sonographic imaging | FEMASYS INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230126871-A1 | METHODS AND DEVICES FOR MANAGING FLUID PRESSURE | FEMASYS INC. | 2023-04-27 | — | — | US | disclosed |
| US-20230066723-A1 | MICROPARTICLE COMPOSITIONS | YEH JAMES SHUE MIN (GB) | 2023-03-02 | — | — | US | disclosed |
| US-11583625-B2 | Methods and devices for managing fluid pressure | FEMASYS INC. (US) | 2023-02-21 | — | — | US | disclosed |
| US-20210378708-A1 | Methods and Devices for Sonographic Imaging | FEMASYS INC. | 2021-12-09 | — | — | US | disclosed |
| US-11154326-B2 | Methods and devices for sonographic imaging | FEMASYS INC. (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200368424-A1 | Methods and Devices for Managing Fluid Pressure | FEMASYS, INC. | 2020-11-26 | — | — | US | disclosed |
| US-20010008626-A1 | ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM | BRACCO INTERNATIONAL B.V. (NL) | 2001-07-19 | — | — | US | disclosed |
| US-6183725-B1 | AN INJECTABLE AQUEOUS SUSPENSION COMPRISING GAS FILLED MICROBUBBLES IN A PHYSIOLOGICALLY ACCEPTABLE AQUEOUS CARRIER INCLUDING AT LEAST TWO BIOCOMPATIBLE GASES | BRACCO RESEARCH S.A. (CH) | 2001-02-06 | — | — | US | disclosed |
| US-6042809-A | USE OF HYPERPOLARIZED GASES TO MAGNETIC RESONANCE IMAGING (MRI) OF LIVING SUBJECTS | BRACCO RESEARCH S.A. (CH) | 2000-03-28 | — | — | US | disclosed |
| US-5961956-A | GAS MICROBUBBLES IMMOBILISED WITHIN A FROZEN AQUEOUS CARRIER LIQUID; THE IMMOBILISED GAS MICROBUBBLES ARE MICROBUBBLES BOUND BY AN EVANESCENT ENVELOPE OR A TANGIBLE MEMBRANE. | BRACCO RESEARCH S.A. (CH) | 1999-10-05 | — | — | US | disclosed |
| US-5846518-A | Gas mixtures useful as ultrasound contrast media contrast agents containing the media and method | BRACCO RESEARCH S.A. (CH) | 1998-12-08 | — | — | US | disclosed |
| US-5830435-A | BOUNDING BY ENVELOP OR MEMBRANE | BRACCO RESEARCH S.A. (NL) | 1998-11-03 | — | — | US | disclosed |
| US-5827504-A | SUSPENSION OF GAS MICROBUBBLES BOUNDED BY EVANESCENT ENVELOPE OR MEMBRANE IMMOBILIZED WITHIN FROZEN CARRIER LIQUID; ECHO IMAGING CONTRAST AGENT | BRACCO RESEARCH S.A. (CH) | 1998-10-27 | — | — | US | disclosed |
| US-5556610-A | FLUORINE CONTAINING GAS, MICROBUBBLES DISPERSED IN AQUEOUS CARRIER | BRACCO RESEARCH S.A. (CH) | 1996-09-17 | — | — | US | disclosed |
| EP-0682530-A1 | GAS MIXTURES USEFUL AS ULTRASOUND CONTRAST MEDIA | BRACCO RESEARCH S.A. (CH) | 1995-11-22 | — | — | EP | disclosed |
| WO-1995016467-A1 | GAS MIXTURES USEFUL AS ULTRASOUND CONTRAST MEDIA | BRACCO RESEARCH S.A. (CH) | 1995-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230066723-A1 | MICROPARTICLE COMPOSITIONS | PHOSPHO1, SGMS2, CHMP4B | LMNA 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.